CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Material agreement · Other events
- 8-K Event Material agreement · Unregistered share sale · Executive or director change
- 8-K Event Material agreement · Agreement ended · New debt or obligation
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change · Shareholder vote results
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Material agreement · Acquisition or sale completed · Delisting notice · Unregistered share sale · Executive or director change · Regulation FD disclosure
- 8-K Event Shareholder vote results · Regulation FD disclosure
- 8-K Event Delisting notice
Page 2 of 4 · 79 filings